Health2047 and Celgene to Enhance Data Liquidity in Healthcare
Ecosystem collaboration to benefit people, physicians, and researchers alike
SAN FRANCISCO, Calif. — Sept. 26, 2017 — Today, Health2047 Inc. announced its collaboration with Celgene Corporation (NASDAQ; CELG) on a groundbreaking healthcare information transfer system. As part of this collaboration, Health2047 is developing a new data transfer protocol for healthcare that will be secure, trusted and connected.
Health2047’s mission is to transform U.S. healthcare at the system level by creating a vibrant ecosystem of best-in-class partners that hail from the healthcare, tech, consumer, and benefit management sectors. Working closely with both the American Medical Association (AMA) and a growing ecosystem of partners, Health2047 is developing and commercializing solutions in the areas of data liquidity, chronic care, productivity, and payments. The Silicon Valley-based company launched in 2016 and has secured $60 million in funding commitments.
“We are delighted to welcome Celgene to the Health2047 ecosystem,” said Dr. Doug Given, Health2047’s Chief Executive. “Close collaboration among leaders in the technology and healthcare sectors is essential to driving meaningful change. Innovative visionaries like Celgene understand the pressing need to create solutions that are able to address large-scale issues like data liquidity and enable better clinical decisions, improve patient outcomes, and enhance value-based care.“
Given Celgene’s deep history and expertise in developing and commercializing life-changing medicines for cancers and inflammatory diseases, Health2047 is excited about collaborating with Celgene as it builds a new data transfer protocol tuned for healthcare. Working together, Celgene and Health2047 will seek to improve secure data sharing among patients, physicians, hospitals, systems, payers, and research partners to move toward a more efficient care model.
“Meeting the data interoperability challenge requires an ecosystem-based approach and a trusted entity like the AMA,” said Celgene’s Vice President Information Knowledge Utilization (IKU), Gertjan Bartlema. “Given the expertise of Health2047’s team and the innovative platform they’re building, we wanted to be a part of the effort. Managing data efficiently while curating knowledge and insights will be key to achieving greater value for patients.”
“Collaboration across technology and healthcare is critical to creating the solutions we need to improve care and outcomes for people,” added Dr. James L. Madara, CEO and Executive Vice President of the AMA. “It’s clear that we have big system-level problems to fix, and none of us can do it alone.”
Health2047 is a Silicon Valley-based innovation enterprise developing and commercializing solutions in the areas of data liquidity, chronic care, productivity, and payments to transform U.S. healthcare at the system level. The company’s deep relationships with both the American Medical Association (AMA) and its ecosystem partners create a unique force multiplier that helps drive large-scale changes in healthcare. For more information about the company, please visit www.health2047.com.